• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Corrigendum] Sulforaphane suppresses the viability and metastasis, and promotes the apoptosis of bladder cancer cells by inhibiting the expression of FAT‑1.[勘误] 萝卜硫素通过抑制FAT-1的表达抑制膀胱癌细胞的活力和转移,并促进其凋亡。
Int J Mol Med. 2022 Jul;50(1). doi: 10.3892/ijmm.2022.5149. Epub 2022 May 26.
2
[Corrigendum] LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL‑6 and TNF‑α.[勘误]LYPD8通过抑制IL-6和TNF-α的分泌来调节结肠癌细胞的增殖和迁移。
Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8004. Epub 2021 Apr 22.
3
[Corrigendum] TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.[勘误]TP53和RET可作为肝细胞癌预后评估和靶向治疗的生物标志物。
Oncol Rep. 2022 Nov;48(5). doi: 10.3892/or.2022.8411. Epub 2022 Sep 21.
4
[Corrigendum] Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway.[勘误] 长链非编码RNA UCA1通过调控EZH2/p21轴和PI3K/AKT信号通路赋予乳腺癌内分泌治疗中的他莫昔芬耐药性。
Int J Oncol. 2024 Mar;64(3). doi: 10.3892/ijo.2024.5611. Epub 2024 Jan 12.
5
[Corrigendum] MicroRNA‑10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer.[勘误] 微小RNA-10b通过KLF4和HOXD10促进人膀胱癌的迁移和侵袭。
Oncol Rep. 2022 Jul;48(1). doi: 10.3892/or.2022.8340. Epub 2022 Jun 1.
6
[Corrigendum] COX‑2 regulates E‑cadherin expression through the NF‑κB/Snail signaling pathway in gastric cancer.[勘误] 环氧化酶-2通过核因子κB/蜗牛信号通路调控胃癌中E-钙黏蛋白的表达。
Int J Mol Med. 2022 Mar;49(3). doi: 10.3892/ijmm.2022.5083. Epub 2022 Jan 11.
7
[Corrigendum] The role of VIT1/FBXO11 in the regulation of apoptosis and tyrosinase export from endoplasmic reticulum in cultured melanocytes.[勘误] VIT1/FBXO11在培养的黑素细胞中对内质网凋亡调控及酪氨酸酶输出的作用
Int J Mol Med. 2022 Feb;49(2). doi: 10.3892/ijmm.2021.5069. Epub 2021 Dec 8.
8
[Corrigendum] Hsa‑circRNA‑G004213 promotes cisplatin sensitivity by regulating miR‑513b‑5p/PRPF39 in liver cancer.[勘误] Hsa-circRNA-G004213通过调控miR-513b-5p/PRPF39促进肝癌顺铂敏感性。
Mol Med Rep. 2021 Oct;24(4). doi: 10.3892/mmr.2021.12359. Epub 2021 Aug 13.
9
[Corrigendum] Dendritic cell‑derived exosomal miR‑494‑3p promotes angiogenesis following myocardial infarction.[勘误] 树突状细胞衍生的外泌体miR-494-3p促进心肌梗死后的血管生成。
Int J Mol Med. 2022 Apr;49(4). doi: 10.3892/ijmm.2022.5096. Epub 2022 Feb 4.
10
[Corrigendum] miR‑27a‑3p regulates the inhibitory influence of endothelin 3 on the tumorigenesis of papillary thyroid cancer cells.[勘误] miR-27a-3p调节内皮素3对甲状腺乳头状癌细胞肿瘤发生的抑制作用。
Mol Med Rep. 2021 Jun;23(6). doi: 10.3892/mmr.2021.12105. Epub 2021 Apr 21.

引用本文的文献

1
Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma.靶向人子宫平滑肌肉瘤的 I 类组蛋白去乙酰化酶。
Cells. 2022 Nov 27;11(23):3801. doi: 10.3390/cells11233801.

[勘误] 萝卜硫素通过抑制FAT-1的表达抑制膀胱癌细胞的活力和转移,并促进其凋亡。

[Corrigendum] Sulforaphane suppresses the viability and metastasis, and promotes the apoptosis of bladder cancer cells by inhibiting the expression of FAT‑1.

作者信息

Wang Fei, Liu Penghua, An Hexiang, Zhang Yu

机构信息

Shenzhen Key Laboratory of Viral Oncology, Clinical Innovation and Research Center, Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong 518101, P.R. China.

Department of Urology, Baoan Central Hospital of Shenzhen, The Fifth Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong 518102, P.R. China.

出版信息

Int J Mol Med. 2022 Jul;50(1). doi: 10.3892/ijmm.2022.5149. Epub 2022 May 26.

DOI:10.3892/ijmm.2022.5149
PMID:35616153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9170190/
Abstract

Following the publication of the above paper, the authors drew the Editor's attention to the fact that their article contained two textual errors located in the same sentence: In the '' subsection of the Materials and methods section on p. 1086 (the first sentence), the text here should have read as follows (changes highlighted in bold): 'In the present study, 85 bladder cancer tissues and 27 adjacent normal tissues were collected from patients with BC who attended the for treatment.' (i.e. the samples were not exclusively collected from the Shenzhen Hospital of Southern Medical University as stated, and the collection dates should have been written as 2014 and 2018, not as 2010 and 2014). The authors are grateful to the Editor of for allowing them the opportunity to publish this Corrigendum, and they apologize for any inconvenience caused to the readership of the Journal. [International Journal of Molecular Medicine 46: 1085‑1095, 2020; DOI: 10.3892/ijmm.2020.4665].

摘要

上述论文发表后,作者提请编辑注意,他们的文章在同一句话中存在两个文本错误:在第1086页材料与方法部分的“”子部分(第一句),原文应如下(加粗部分为修改内容):“在本研究中,从前往接受治疗的膀胱癌患者中收集了85份膀胱癌组织和27份相邻正常组织。”(即样本并非如所述仅从南方医科大学深圳医院收集,收集日期应为2014年和2018年,而非2010年和2014年)。作者感谢《国际分子医学杂志》编辑给予他们发表此勘误的机会,并就给该刊读者带来的不便表示歉意。[《国际分子医学杂志》46: 1085 - 1095, 2020; DOI: 10.3892/ijmm.2020.4665]